Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Updates

 This is to inform you that the US FDA has completed inspection of Company's formulations manufacturing facility (SEZ unit) located at Jadcherla, Telangana, India which was inspected between 24th July and 28th July 2017. The inspection has now been closed by the US FDA with one minor observation. The Company is in the process of submission of corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines in response to the form 483 issued at the end of inspection.
31-07-2017
Bigul

Shareholding for the Period Ended June 30, 2017

 Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here
20-07-2017
Bigul

Statement Of Investor Complaints For The Quarter Ended 30.06.2017.

 In Compliance with the requirement under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find the statement of investor Complaints/Grievances for the quarter 1st April, 2017 to 30th June, 2017.
20-07-2017
Bigul

Revised Financial Results For The Quarter And Year Ended 31/03/2017.

 With reference to your e-mail, we herewith enclosed the revised financial results for the quarter and year ended 31st March, 2017.
15-07-2017
Bigul

Declaration regarding Audit Report

 Shilpa Medicare Ltd has informed BSE regarding Declaration regarding Audit Report for Financial Results for Period ended March 31, 2017.
12-07-2017
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasvantlal Chhotalal & Co Pvt Ltd
14-06-2017
Bigul

Updates

 Submission of Reconciliation of Equity as on 31st March 2016 for the standalone and consolidated financial results Quarter ended 31.03.2017.
12-06-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukanth C Bhutada
31-05-2017
Bigul

Modified Consolidated Financial Results For The Fourth Quarter And Financial Year Ended 31/03/2017.

 We herewith submit Modified Consolidated Financial Results for the quarter ended 31st March, 2017 as there were typographical error in the submitted financial results. We further submit that there would be no change in the profits due to said modification as the modification relating to the grossing up of excise duty in total income and charging as expense.
30-05-2017
Bigul

Audited Financial Results For The Quarter And Year Mar 31, 2017

 Submission of Audited Financial Results for the Quarter ended Mar 31, 2017 along with Auditors' Report and declaration Unmodified Auditors' Opinion.
29-05-2017
Next Page
Close

Let's Open Free Demat Account